Page last updated: 2024-08-21

hexafluoroacetone and Multiple Sclerosis

hexafluoroacetone has been researched along with Multiple Sclerosis in 1 studies

*Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guardiani, C; Livi, R; Papini, AM; Procacci, P; Signorini, GF1

Other Studies

1 other study(ies) available for hexafluoroacetone and Multiple Sclerosis

ArticleYear
Conformational landscape of N-glycosylated peptides detecting autoantibodies in multiple sclerosis, revealed by Hamiltonian replica exchange.
    The journal of physical chemistry. B, 2012, May-10, Volume: 116, Issue:18

    Topics: Acetone; Amino Acid Sequence; Autoantibodies; Fluorocarbons; Glycopeptides; Glycosylation; Molecular Dynamics Simulation; Multiple Sclerosis; Oligopeptides; Peptide Fragments; Protein Conformation; Protein Folding; Solvents; Water

2012